Sumitomo Mitsui Trust Amends PacBio Stake Disclosure
Ticker: PACB · Form: SC 13G/A · Filed: Feb 5, 2024 · CIK: 1299130
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, SC-13G, investor-update
TL;DR
**Sumitomo Mitsui Trust updated their PacBio ownership, signaling a change in their institutional stake.**
AI Summary
Sumitomo Mitsui Trust Holdings, Inc. filed an amended Schedule 13G/A on February 5, 2024, indicating a change in their beneficial ownership of Pacific Biosciences of California, Inc. common stock as of December 31, 2023. This amendment, filed under Rule 13d-1(b), updates their previous disclosures regarding their investment in the genetic sequencing technology company. This matters to investors because it provides transparency into significant institutional ownership changes, which can sometimes signal confidence or lack thereof in the company's future prospects.
Why It Matters
This filing updates the public record on a major institutional investor's position in Pacific Biosciences, offering insight into their current level of commitment to the company.
Risk Assessment
Risk Level: low — This is a routine amendment filing by an institutional investor and does not inherently indicate significant risk for the company.
Analyst Insight
An investor should note this filing as a routine update from a significant institutional holder. While it doesn't provide specific share counts in the provided text, it signals ongoing institutional interest. Further investigation into the full filing would be needed to understand the exact change in ownership percentage and its potential implications.
Key Players & Entities
- Sumitomo Mitsui Trust Holdings, Inc. (company) — the institutional investor filing the SC 13G/A
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (company) — the subject company whose stock is being reported
- NIKKO ASSET MANAGEMENT CO., LTD. (company) — a group member associated with the filing
- December 31, 2023 (date) — the date of the event requiring the filing
- February 5, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'AMENDMENT NO. 2'.
Who is the subject company of this filing?
The subject company is PACIFIC BIOSCIENCES OF CALIFORNIA, INC., as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'.
Who is the entity that filed this SC 13G/A?
The entity that filed this SC 13G/A is Sumitomo Mitsui Trust Holdings, Inc., as indicated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Sumitomo Mitsui Trust Holdings, Inc.'.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock, par value $0.001 per share, of Pacific Biosciences of California, Inc. is 69404D108, as listed on the cover page.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified on the cover page.
Filing Stats: 1,420 words · 6 min read · ~5 pages · Grade level 7.4 · Accepted 2024-02-05 06:08:57
Key Financial Figures
- $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
Filing Documents
- pacbio130247sc13ga2.htm (SC 13G/A) — 61KB
- 0001214659-24-001846.txt ( ) — 63KB
(a). Name of Issuer
Item 1(a). Name of Issuer: Pacific Biosciences of California, Inc.
(b). Address of Issuer’s Principal Executive Offices
Item 1(b). Address of Issuer’s Principal Executive Offices: 1305 O’Brien Drive Menlo Park, California 94025
(a). Name of Person Filing
Item 2(a). Name of Person Filing: Sumitomo Mitsui Trust Holdings, Inc. Nikko Asset Management Co., Ltd.
(b). Address of Principal Business Office or, if None, Residence
Item 2(b). Address of Principal Business Office or, if None, Residence: SMTH: 1-4-1 Marunouchi, Chiyoda-ku, Tokyo 100-8233, Japan NAM: Midtown Tower, 9-7-1 Akasaka, Minato-ku, Tokyo 107-6242, Japan
(c). Citizenship
Item 2(c). Citizenship: SMTH: Japan NAM: Japan
(d). Title of Class of Securities
Item 2(d). Title of Class of Securities: Common Stock, par value $0.001 per share
(e). CUSIP Number
Item 2(e). CUSIP Number: 69404D108 Page 4 of 9
If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
Item 3. If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: SMTH: (a) o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) o Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) o Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) x A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) x A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); (k) o Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: Parent Holding Company NAM: (a) o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) o Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) o Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) x A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) o
Ownership
Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of issuer identified in Item 1. SMTH: (a) Amount beneficially owned: 13,200,375 (b) Percent of class: 4.93% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 13,200,375 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 13,200,375 NAM: (a) Amount beneficially owned: 13,200,375 (b) Percent of class: 4.93% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 13,200,375 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 13,200,375 Page 6 of 9
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. x
Ownership of More than Five Percent on Behalf of Another Person
Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable.
Identification and Classification of the Subsidiary Which Acquired
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. See Exhibit A.
Identification and Classification of Members of the Group
Item 8. Identification and Classification of Members of the Group. Not applicable.
Notice of Dissolution of Group
Item 9. Notice of Dissolution of Group. Not applicable.
Certifications
Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 7 of 9 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 5, 2024 Sumitomo Mitsui Trust Holdings, Inc. (Company) /s/ Hideaki Takamiya (Signature) Hideaki Takamiya / Senior Manager of Risk Management Dept (Name/Title) Nikko Asset Management Co.,Ltd (Company) /s/ Atsushi Ohya (Signature) Atsushi Ohya / Head of Business Regulatory Compliance (Name/Title) Page 8 of 9 Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the securities being reported on by each of SMTH and NAM, as parent holding companies, are owned, or may be deemed to be beneficially owned, by their subsidiary Nikko Asset Management Americas, Inc., which is classified as an investment adviser in accordance with §240.13d-1(b)(1)(ii)(E). Page 9 of 9